Skip to content

Modified sequential method to determine the half effective dose of alfentanil compounded with propofol for ambulatory hysteroscopy

Modified sequential method to determine the half effective dose of alfentanil compounded with propofol for ambulatory hysteroscopy

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200061619
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-06-15
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

daytime hysteroscopy

Interventions

case series:Alfentanil (modified sequential method) + propofol

Sponsors

Nanjing Maternity and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Women who will undergo hysteroscopic surgery; 2. Aged 18-55 years; 3. American Society of Anesthesiologists (ASA) classification I-II.

Exclusion criteria

Exclusion criteria: 1. Patients who refuse to participate in the trial; 2. Those with a history of severe cardiac, cerebral, pulmonary, hepatic, renal and metabolic disease; 3. Those with a history of previous recovery from abnormal surgical anesthesia; 4. ECG suggestive of a heart rate 180 mmHg and/or diastolic blood pressure > 110 mmHg, or hypotensive patients < 90/60 mmHg; 7. Patients with neuromuscular system diseases and psychiatric diseases; 8. Patients with anemia; 9. Those with suspected abuse of narcotic analgesics or sedatives; 10. Those with known allergy to emulsions and opioids.

Design outcomes

Primary

MeasureTime frame
body movement response;blood pressure;heart rate;

Countries

China

Contacts

Public ContactShanwu Feng

Nanjing Maternity and Child Health Care Hospital

shanwufeng@163.com+86 13921426351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026